CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 4,832 enrolled
Drug / intervention
Usual Care +1 moreother
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT03207776
NCT03207776N/ACompleted

A Cluster Randomized, Stepped-Wedge Evaluation of Post Discharge Utilization Among Patients With an Acute Exacerbation of Chronic Obstructive Pulmonary Disorder (COPD)

Wake Forest University Health Sciences·interventional·Posted Jul 5, 2017·Updated Apr 22, 2022

In Brief

A clinical study evaluating Usual Care and COPD Clinical Pathway for Chronic Obstructive Pulmonary Disease. Completed, enrolled 4,832 participants across 8 sites.

Detailed Summary

Patients who are hospitalized at select Carolinas Healthcare System (CHS) sites with Chronic Obstructive Pulmonary Disorder (COPD) acute exacerbation symptoms will be treated per the CHS COPD Clinical Pathway. Patient outcomes will be followed, including but not limited to readmission. Patients on the pathway will also have access to navigator services.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
CountriesUnited States
Collaborators--

Timeline

N/ACompletedFinished
201820192020202120222023202420252026
First PostedJul 5, 2017
Enrollment StartJun 12, 2017
Primary CompletionFeb 12, 2018
Study CompletionAug 13, 2018
TodayJul 2, 2026
Enrollment to primary: 8 monthsPosted 9.0 years ago

Interventions

Usual Careother

Treatment of patients in the usual manner based on their diagnosis and resources available at that site.

COPD Clinical Pathwayother

A group of 4 Usual Care components that are applied consistently and completely amongst all patients who present with COPD acute exacerbation symptoms, plus access to navigator services.